Navigation Links
Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
Date:9/5/2012

eir implementation including IND filing, mid-stage development, license applications, preparations, approval, label extension and post market phase in the global setting (US, Canada, Europe, Canada, Asia). Prior to Pharmacyclics Dr. Gayko served as VP of Regulatory and Clinical Affairs at Nodality and as Global Regulatory Leader at Amgen, where she had also worked as a Global Program Manager and Senior Clinical Research Manager.

Rick Love is serving as Vice President, Legal. He has over 19 years of experience working as in-house counsel in the biotech/pharma industry. For the past three years, he worked for the IPSEN Group, most recently in the position of Vice-President, Head of Patents, U.S.A. Before IPSEN, he practiced in the areas of intellectual property and corporate law at Tercica. Before Tercica, Mr. Love was the Senior Director, Intellectual Property at InterMune and served for eight years at Genentech as Patent Counsel. He holds a J.D. from Golden Gate University School of Law and a B.A. in Mathematics from Hamilton College.

To access a more complete resume for each of these managers and to review the full management team, visit Pharmacyclics' website at: http://www.pharmacyclics.com/pharmacyclics_management.html

Janssen CollaborationThe partnership with Janssen Biotech, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, is progressing well. Since signing the agreement in December 2011, the companies have established numerous working groups, each with a defined area of responsibility in the overall development plan. Currently there are over 200 dedicated employees in both companies engaged in these Working Groups, forwarding the clinical progress of ibrutinib and ensuring the execution of the Global Development Plan for this compound. The partnership also established a Joint Development and Joint Steering Committee to oversee and
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
2. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
10. Luminex Corporation Reports First Quarter 2012 Results
11. Hospira Reports First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... YORK , May 23, 2013  Intercept Pharmaceuticals, ... stage biopharmaceutical company focused on the development and commercialization ... diseases, such as primary biliary cirrhosis, today announced that ... Chief Executive Officer, will present at the Deutsche Bank ... Boston on Wednesday, May 29, 2013 at ...
(Date:5/23/2013)...  MedVantx, Inc., the company that has pioneered a ... the Company has completed a major expansion of its ... and the upgrade of its systems to offer a ... specialty home delivery pharmacy in Sioux Falls, ... physicians, health systems and payors novel distribution services, as ...
(Date:5/23/2013)... PARIS , May 23, 2013 ... (NYSE MKT: NSPR), the leader in embolic protection ... MASTER (MGuard for Acute ST Elevation Reperfusion) trial ... outperformed bare metal and drug eluting stents in ... (STEMI) patients.  Results from the trial were presented ...
Breaking Medicine Technology:MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
... FOREST, Ill., Sept. 6, 2011 Hospira, Inc. ... in generic injectable pharmaceuticals, today announced positive results from ... erythropoietin (EPO) in patients with renal (kidney) dysfunction who ... equal pharmacokinetics, or blood level and distribution in the ...
... 2011 Johnson & Johnson (NYSE: JNJ ) ... Tuesday, September 13 th , at the Grand Hyatt New ... New York, NY.  Dominic Caruso, Vice President, Finance and Chief ... the company in a session scheduled at 10:20 a.m. (Eastern). ...
Cached Medicine Technology:Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 2Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 3
(Date:5/23/2013)... UNITED KINGDOM (PRWEB) May 24, 2013 ... by A.L. Hodkin, A.F. Huxley and B. Katz in ... to account for the role of sodium and potassium ... electrophysiological techniques and the data acquisition techniques have known ... Yves Pichon wants to give an account of ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Voyance, ... and perception management tools, and ASCA, the industry’s ... the new ASCA Benchmarking Program. Voyance ... technology and national benchmarking experience to support ASCA’s ... comprehensive, state-of-the-art benchmarking tool. , “Voyance is both ...
(Date:5/23/2013)... FL (PRWEB) May 23, 2013 Onlinefitnessreview.com ... Belly Blast Diet to determine what makes this diet ... The published review highlights three main components of the ... achieving a positive mindset and the personal motivation that ... intake every 7 days to keep the metabolism rate ...
(Date:5/23/2013)... -- People who eat at fast-food restaurants are consuming ... are the worst offenders, a new study found. ... by as much as 34 percent, parents of school-age ... by as much as 20 percent," study lead researcher, ... the Robert Wood Johnson Foundation, which helped fund the ...
(Date:5/23/2013)... 23, 2013 Susquehanna Health ... a comprehensive babysitting training course for adolescents age 11 ... by Indianapolis pediatrician Dr. Patricia Keener after a colleague’s ... an adult sitter who didn’t know how to provide ... program with a medical basis that aims to reduce ...
Breaking Medicine News(10 mins):Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 2Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 3Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 2Health News:Voyance and ASCA Announce Strategic Partnership to Better the ASC Industry 3Health News:Onlinefitnessreview.com Publishes 7 Day Belly Blast Diet Review 2Health News:How Many Calories in Your Fast-Food Meal? Guess Again 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 3
... ... to help clothe children in need. , ... Miami, FL (PRWEB) Dec. 16, 2009 -- South Florida dry cleaner Dryclean USA Florida , ... to help clothe children in need by collecting funds on behalf of indigent and needy families. ...
... ... been brought into reach for many Houstonians with the announcement by Hearing Haven, LLC of ... ... into reach for many Houstonians with the announcement by Hearing Haven, LLC of a new ...
... , ... engaged in the development of products that help survivors of stroke and other forms of ... of their brand new device for stroke rehabilitation, the Tailwind. (Advance for Physical Therapy and ... , ...
... ... Foods store. , ... FL (PRWEB) December 16, 2009 -- Dr. Larry Shapiro, hair transplant and hair loss ... Hair Whey Protein Shake. Dr. Shapiro developed the all natural growth-hormone free, hair vitamin, protein ...
... , , BALTIMORE, Dec. 15 ... the Patient Protection and Affordable Care Act that would have ... safe and legal importation of lower priced drugs from abroad. ... Dorgan, Snowe, McCain, Grassley and Stabenow, would have improved competition ...
... SUNNYVALE, Calif., Dec. 15 Palo Alto Networks(TM), the ... deployed its PA-4000 Series next-generation firewalls for accurate threat ... and control over applications such as peer-to-peer file sharing. ... eight facilities on five campuses. The university was founded ...
Cached Medicine News:Health News:Pay a Dollar, Dress a Child: Helping Struggling Families with Small Donations 2Health News:Monthly Subscription Hearing Aid Plan Announced for Houston 2Health News:New Tailwind Device Improves Arm Function in Stroke Survivors with Paralysis 2Health News:Florida Whole Foods Stores to Carry Dr. Lawrence Shapiro's Help Hair Shake 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3
... design of Sleepscan VISION ensures flexibility in ... opportunities. Sleepscan VISION utilizes the powerful Netlink ... through a standard Ethernet connection. Only computer ... allowing the Sleepscan VISION to take advantage ...
... Digital EEG ,The company that introduced ... the latest addition to the Ceegraph ... innovative system incorporates the latest developments ... management to offer you unprecedented portability, ...
... MOBEE headboxes are ... XLTEK's line of portable ... with a robust new ... latest software, XLTEK's standard ...
... SL 130 Slit Lamp is an all-in-one instrument ... structured design also allows the SL 130 to ... achieved by the possibility of operating the slit ... left or right hand. The instrument configuration allows ...
Medicine Products: